Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
CN¥ 8.32
Key Takeaways
Risk factor
High price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Very low or no dividends
Data is available to registered users only
Data is available to registered users only
About
Improve Medical Instruments Co., Ltd. provides technologies, products, and services for clinical laboratory and clinical nursing in China and internationally. Its principal products include IMPROVACUTER evacuated blood collection systems, IMPROMINI capillary blood collection systems, IMPROSWAB microbiological transportation systems, IMPRONURSE infusion pumps and syringe pumps, LONGX urine analysis systems, in-vitro diagnostic reagents, etc. The company also...
Company Valuation
From both historical and forecast perspectives, the stock is fairly priced compared to similar stocks. In particular, the stock is trading at neutral levels on P/FCF.
Data is available to registered users only
Buy
Sell